Eli Lilly and Co (LLY) P/FCF 106.2 | Overview

Search global stocks & ETFs...Ctrl K

Learn Mode

Eli Lilly and CoLLY

$1,182.26

$13.09 (1.120%)

1:49 PM

4.48/5

General

Scores

Financials & KPIs

Dividends

Analyst

Insider

Updates

LLY

Stock Profile

Market Cap

Industry

EPS (TTM)

P/E (TTM)

Div & Yield

FCF Payout Ratio

P/S (TTM)

P/B

Revenue Growth (TTM)

EPS CAGR (3Y)

Diluted Shares

Ex-Dividend

Next Earnings

Forward P/E

Payout Ratio

P/FCF (TTM)

FCF Yield

Earnings Yield

Revenue CAGR (3Y)

Recommended Metric

Score Card

Explore Scores Tab

4.48

Very Good

Eli Lilly and Co has grown revenue at 47.44% over the past year, which is strong growth. Also, it has seen its diluted average shares outstanding decrease by -0.52% over the past year, which suggests the company is buying back shares.

Valuation Score

Key Score

4.00

Good

Management

4.00

Good

Growth

2.00

Bad

Profitability

4.00

Good

Fin. Health

4.00

Good

Dividends

4.00

Good

Analyst

5.00

Very Good

Financials

Explore Financial Tab ›

Revenue

Earnings

Free Cash Flow

Insider Transactions

Explore Insider Tab ›

Buy Transactions

Sell Transactions

Peers

Select stocks to compare

ELANElanco Animal Health Inc

AXSMAxsome Therapeutics Inc

BMYBristol-Myers Squibb Co

RPRXRoyalty Pharma Plc

Price Targets & Ratings

View Analysis

1-year price targets, ending Jun 28, 2027

Current

$1,182

Baseline

High

$1,575

▲

33.22%

Avg

$1,237

▲

4.59%

Low

$859

▼

-27.38%

Analyst Ratings based on 38 Analysts

Strong Buy

29%

Buy

50%

Hold

18%

Sell

03%

Strong Sell

00%

About

Stock News

View All Updates